Aurobindo, Hetero, and Vivimed Class Action Settlements in Kansas
Aurobindo, Hetero, and Vivimed class action settlements that covered Kansas residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Kansas residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Kansas Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Kansas
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Kansas residents affected by the $15.2 million Valsartan, Losartan and Irbesartan class action settlement involving Aurobindo, Hetero, and Vivimed pharmaceutical companies should understand their rights under Kansas consumer protection laws. The Kansas Consumer Protection Act provides additional remedies for deceptive trade practices, which may complement federal class action recoveries. These three pharmaceutical manufacturers supplied generic blood pressure medications containing NDMA impurities to distributors across Kansas, reaching patients through major pharmacy chains including CVS, Walgreens, and Walmart locations throughout the state. Kansas operates under a modified comparative negligence standard, which can affect how damages are calculated in pharmaceutical litigation. The state's statute of limitations for personal injury claims is typically two years, though class action settlements often have separate filing deadlines. Kansas residents must file claims within the court-approved deadline to participate in the settlement, and the state's Department of Health and Environment has tracked the recall of affected medications distributed to Kansas pharmacies between 2012 and 2018.
Aurobindo, Hetero, and Vivimed Settlements in Kansas: FAQs
What medications are covered in the Aurobindo, Hetero, and Vivimed settlement for Kansas residents?
The $15.2 million settlement covers Valsartan, Losartan, and Irbesartan generic blood pressure medications manufactured by these companies and distributed to Kansas pharmacies. These medications contained NDMA impurities that were linked to increased cancer risk. Kansas residents who purchased these specific generic versions between 2012 and 2018 may be eligible for compensation.
How does Kansas law affect my ability to file additional claims against these pharmaceutical companies?
Kansas Consumer Protection Act may allow residents to pursue separate state law claims for deceptive practices beyond the federal class action settlement. However, participating in the class action settlement typically requires waiving rights to individual lawsuits. Kansas residents should consult with attorneys familiar with state pharmaceutical liability laws before deciding whether to opt out of the settlement.
Are there specific documentation requirements for Kansas residents filing claims in this settlement?
Kansas residents need pharmacy records, prescription bottles, or insurance records showing they purchased the affected Valsartan, Losartan, or Irbesartan medications from these manufacturers. The Kansas Board of Pharmacy maintains records that may help verify which generic versions were distributed to specific pharmacies during the relevant time period. Medical records showing related health issues may increase compensation amounts.
Tips for Kansas Residents Filing Aurobindo, Hetero, and Vivimed Claims
Kansas residents filing claims in the Aurobindo, Hetero, and Vivimed settlement should gather prescription records from all Kansas pharmacies where they filled affected medications. Contact your insurance company for prescription history if pharmacy records are unavailable. The Kansas Board of Pharmacy website provides manufacturer information that can help identify whether your specific generic blood pressure medication was produced by these companies. File claims before the court-approved deadline, as Kansas state law cannot extend federal class action filing periods. Consider consulting Kansas-licensed attorneys familiar with pharmaceutical settlements, as the state's consumer protection laws may provide additional remedies. Keep copies of all submitted documentation and track your claim status through the settlement administrator's website.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
